Alternatives to The Galen Platform

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Concentriq, our advanced AI-driven software platform, operates at the crucial crossroads of digital and computational pathology, merging essential functionalities for routine pathology tasks with robust AI tools that enhance innovations and elevate patient care quality. Pathology laboratories around the globe are acutely aware of the contemporary hurdles, which include an escalating cancer incidence, a shortage of trained pathologists, diminishing reimbursement rates, and the urgent need for modernization. In this context, with one billion pathology slides projected to transition to digital formats annually, generating enormous volumes of new data and insights, the urgency to act is undeniable. Digital pathology equips today’s progressive pathology organizations with the resources necessary to tackle these challenges effectively, thereby revolutionizing our operational methods and significantly impacting the fields of medicine and patient treatment. As this transformation unfolds, the potential for improved diagnostics and enhanced patient outcomes continues to grow exponentially.

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

AES Medical's PathoSys® cellular pathology reporting software has been developed in collaboration with consultant pathologists and was the inaugural system to gain recognition from the Royal College of Pathologists (RCPath). By integrating datasets from the Royal College of Pathologists, this software enables standardized reporting and structured data capture, which in turn allows for swift real-time auditing and the export of structured pathology data to authorized third parties. The integration with laboratory systems eliminates the necessity for duplicate entries of demographic and report information while streamlining report distribution. Designed from the ground up, the Pathology Network accommodates multiple laboratories, promoting comprehensive network-wide reporting and auditing capabilities. With its user-friendly interface, the software facilitates rapid real-time searches and audits, effectively shifting the workload balance from data collection to analysis, thereby enhancing the efficiency of clinical audits. This innovative approach not only streamlines processes but also ensures a higher quality of patient care through better data management.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

CaseManager DX is an innovative pathology information system aimed at streamlining the entire digital pathology process by consolidating case management, patient records, digital slide integration, and diagnostic reporting into one compliant platform that connects electronic health records and laboratory information systems through HL7 and secure interoperability, catering to both clinical and hospital environments. This system interfaces directly with digital pathology scanners to capture, organize, and archive high-resolution images of histology and cytology slides along with essential clinical and demographic information, allowing pathologists to access comprehensive case details, patient histories, diagnoses, slides, attachments, quantifications, and image analysis results all in one place, while also facilitating standard report writing and clinical documentation. Furthermore, it enhances storage efficiency through SlideStorage DX, provides an intuitive viewing experience with ClinicalViewer, enables teleconsultation for remote collaborative diagnostics, and ensures effective workflow coordination among healthcare professionals. The integration of these features not only improves diagnostic accuracy but also fosters better communication and collaboration within healthcare teams.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

Efficiently generating reports for NGS-based clinical tests necessitates a well-established and sophisticated platform that can automatically prioritize variants, interpret clinical data, and create comprehensive reports. Strand Omics serves as a rapid, HIPAA-compliant cloud platform that enhances our clinical diagnostics efforts, having been refined over four years through the analysis of more than 10,000 clinical reports and numerous peer-reviewed studies. This platform integrates advanced bioinformatics algorithms with curated databases, intuitive visualization tools, and robust reporting features. It is designed with specialized workflows tailored for both rare inherited conditions and somatic tumor profiling assays. Additionally, the system boasts a library of over 10,000 somatic variants that have been curated for their oncogenic potential, alongside 100 genes selected for their druggability across various cancer types, as well as 500 drugs that have been validated for efficacy against multiple cancers. Furthermore, its comprehensive approach ensures that healthcare professionals have access to critical data, ultimately facilitating informed decision-making in patient care.

The integrated mammography viewer allows for ergonomic reading of a diverse range of breast imaging studies alongside other specialty examinations, all conveniently located in one interface. By streamlining workflows, it facilitates quicker reading in high-volume settings, resulting in increased patient throughput. The incorporation of Artificial Intelligence enhances physician efficiency, reduces false negatives in cancer detection, and contributes to the quality assurance of imaging results. A holistic telemammography solution serves as a vital link to expanding access to breast expertise, ultimately leading to improved diagnostic accuracy and patient outcomes. The NovaMG PRO can function as an independent workstation compatible with any PACS or mammography technology. Additionally, the breast care workflow module is included within NovaPACS EI, and current users can activate it in just a few minutes, enhancing their existing systems. This integration not only simplifies the process but also empowers healthcare professionals to deliver better care to patients.

DeePathology STUDIO offers a user-friendly platform where pathologists and researchers can independently create AI solutions that address critical challenges in the field of Pathology, all from the convenience of their lab laptops. Utilizing the capabilities of DeePathology STUDIO, users can develop "black box" solutions that function as decision support systems for pathologists. We invite you to either download our H. Pylori Detector or participate in validating our TB detector. With a strong history of successful AI projects in pathology, we are equipped to develop tailor-made solutions that align with your specific objectives, ensuring that your unique needs are met effectively. Additionally, our ongoing commitment to innovation empowers users to stay at the forefront of advancements in pathology AI.

Enhance the Patient Journey by actively engaging, educating, and empowering individuals through improved health communications. Utilize a Patient Engagement Platform to tailor optimal care plans for various medical pathways, such as prostate and breast cancer. Develop a Patient Engagement Pathway that organizes communication strategies in accordance with each care plan's requirements. Streamline the organization of communications by creating or sourcing a variety of supportive materials, including messages, documents, and videos, that correspond to different phases of the care plan. Establish clear communication rules that specify who receives which communications and at what times, ensuring timely delivery of essential information. Integrate new patients into the system effortlessly by matching their specific needs with the appropriate pathway. Finally, centralize all patient-facing communications in one location, allowing for the efficient dissemination of messages, documents, forms, videos, and health widgets. By doing so, healthcare providers can enhance the overall patient experience and foster better health outcomes.

The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.

Inspirata is a specialized oncology data and analytics platform built to help cancer programs improve care delivery and operational performance. It leverages AI-driven technology to automate cancer casefinding, data extraction, and reporting with high accuracy. The platform supports compliance with regulatory requirements while significantly reducing manual registry work. Inspirata transforms unstructured clinical data into actionable insights that fuel research and clinical decision-making. Real-time data access helps improve trial accrual and ensures equitable patient access to clinical studies. Patient navigation tools support coordinated care from screening to survivorship. By improving efficiency, Inspirata allows staff to focus on higher-value patient and research activities. The platform integrates seamlessly with major EHR and clinical systems. Trusted by hundreds of hospitals, Inspirata delivers measurable improvements in oncology operations. It helps cancer centers maximize impact while minimizing cost and complexity.

Explore our efficient screening tools designed to identify patients at a high risk for breast, colorectal, and other types of cancer. Progeny Clinical streamlines the management of family histories, risk assessments, and treatment options for your patients. You can gather family history information online and automatically create pedigrees prior to the clinic appointment. Modify existing pedigrees or create new ones at any time. Execute validated hereditary cancer risk assessment models with a single click, eliminating the need to re-enter data. Simplify the process by ordering genetic testing through Ambry Genetics. Monitor and analyze results from any laboratory without leaving the software environment. Enhance efficiency by generating letters, consultation notes, reports, and documents using custom templates that incorporate patient data fields. Utilize pre-configured or tailored data input screens to swiftly create custom queries and spreadsheet reports. Moreover, you can integrate a hyperlink within your electronic medical record to conveniently access the patient’s latest pedigree. This innovative approach not only saves time but also optimizes patient care and enhances workflow efficiency.

CADU, a cloud-enabled AI solution created by Odin Vision, is designed to aid in identifying and characterizing dysplasia in individuals with Barrett’s oesophagus during gastroscopy. The system evaluates areas that visually resemble Barrett’s oesophagus and offers insights to help clinicians determine whether the tissue is dysplastic or non-dysplastic. By improving the decision-making process for endoscopists and expediting the examination of the oesophagus, CADU proves to be both time-efficient and cost-effective. Additionally, it functions on a platform that is vendor-neutral, facilitating its use with various endoscopic equipment. The system is CE marked and holds UKCA approval; however, it is not available for commercial sale in the United States. CADU has been adopted in clinical environments, including University College London Hospitals, aiming to enhance the detection of early oesophageal cancer, which can often be difficult to identify due to the subtle nature of initial lesions. Its implementation represents a significant advancement in the early diagnosis of this serious condition, highlighting the importance of technology in modern medicine.

Cloud Pathology (CP) is transforming the landscape of diagnostics in the modern era. By leveraging cutting-edge cloud computing technology, it enhances the efficiency of pathology laboratories by an impressive 80%. This innovative system connects seamlessly with all compatible equipment, allowing for streamlined operations. Enjoy a more relaxed lifestyle as Cloud Pathology handles the more demanding tasks, enabling you to oversee processes without stress. It's designed to be the ultimate solution for managing your laboratory needs. Accessible from any device worldwide, pathologists can now review and finalize their reports without the need to rush back to the lab. This advancement not only conserves critical time but also boosts overall efficiency by 35%. Once reports are verified by the responsible physician, they can be automatically dispatched without any manual effort required. Our philosophy prioritizes automation, minimizing human involvement wherever possible. The system is programmed to alert you only when your attention is necessary, ensuring a smooth and efficient workflow. With Cloud Pathology, the future of lab management is not just promising—it's here.

Color delivers one of the most user-friendly, high-quality genetic testing services currently on the market, examining genetic markers linked to the likelihood of developing prevalent cancers and heart diseases, as well as how individuals metabolize specific medications. Our comprehensive range of services, tools, and expertise is designed to facilitate the enrollment of new patients and guide them through personalized care journeys that evolve over time. By taking a holistic approach to patient health, we integrate genetic data, personal and family medical histories, along with lifestyle and behavioral factors to identify and suggest tailored care options or solutions that align with each patient's unique risk profile. This multifaceted strategy ensures that patients receive relevant recommendations that can significantly impact their health outcomes.

Pathology Reporting Software stands out as one of the premier Diagnostic Center Management Software options in India, serving also as a Referral Laboratory Software. It is designed to function in both a network-based and standalone model, making it versatile for various operational needs. Additionally, it can serve as diagnostic center billing software, proving its utility across different applications. This fully tested and reliable pathology laboratory software simplifies tasks with features like report generation, lab accounting, and stock entry, thereby enhancing workflow efficiency. The software provides pathology labs with a highly adaptable data module specifically intended for the distribution and recording of information related to all tests conducted in the lab. It is specifically designed to centralize the entire database and modules of clinics, medical laboratories, diagnostic centers, and pathological laboratories into a single unified interface. Information related to test billing, report delivery, and various other functions can be easily accessed and maintained through this comprehensive system, ensuring seamless operation in busy lab environments. Ultimately, this software not only streamlines processes but also significantly improves the accuracy and reliability of lab operations.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.

Riverain Technologies has developed ClearRead Xray, a suite of five applications that have received FDA clearance, aimed at improving the speed and precision of interpreting chest X-rays within healthcare settings, all without the need for extra equipment, procedures, or exposure to radiation. This innovative platform utilizes specialized suppression technology to create a clear view of the chest, which significantly aids in the swift and precise identification of cardiothoracic conditions. Among its standout features are the generation of bone-suppressed images that enhance visualization, the ability to spot potential lung cancer nodules, a decrease in the time required to read portable X-rays, automatic comparisons with previous examinations to emphasize changes, and compatibility across various imaging devices and protocols throughout the enterprise. Additionally, the ClearRead Xray Bone Suppress feature notably enhances soft tissue visibility by minimizing the presence of bone structures in digital images, thereby assisting radiologists in uncovering nodules that may have previously gone unnoticed. This comprehensive approach not only boosts diagnostic capabilities but also streamlines workflow in busy medical environments.

TrueMedLIS is a cloud-based platform that combines laboratory information management and customer relationship management to streamline and automate various laboratory functions, ranging from sample collection and analysis to data interpretation and reporting, while catering to a wide array of fields such as infectious diseases, COVID-19, cancer genomics, pharmacogenomics (PGx), toxicology, hematology, and other specialized lab areas. By replacing outdated manual methods like paper-based faxes and isolated systems, it facilitates digital order management, provides user-friendly portals for both physicians and patients, and features dedicated interfaces for sales and lab administrators, all with the goal of boosting operational efficiency and minimizing data entry mistakes. Additionally, it seamlessly integrates with pre-existing systems such as billing services and pharmacy benefits management tools, offers real-time analytics along with customizable reporting options in various formats such as Excel and CSV, and is designed with a strong emphasis on security and round-the-clock customer support. This comprehensive approach not only enhances laboratory productivity but also contributes to more accurate and timely patient care outcomes.

Mamosis offers a cutting-edge AI-powered cancer diagnosis solution that accelerates and improves diagnostic accuracy by analyzing complex medical images and wellness metrics. The platform’s deep learning algorithms, developed with input from clinical experts, identify subtle patterns and anomalies that aid in early cancer detection. Mamosis delivers detailed, easy-to-interpret reports quickly, allowing clinicians to initiate timely interventions. The user-friendly interface streamlines the diagnostic process, enabling secure uploads and fast analysis, saving valuable time in clinical settings. With stringent data encryption and privacy protocols, patient information is protected at every step. Mamosis not only aids medical professionals but also empowers individuals by providing personalized health insights for proactive wellness management. The software integrates seamlessly into existing workflows, enhancing efficiency without disrupting daily operations. By fostering collaboration between AI and human expertise, Mamosis drives more accurate diagnoses and improved patient care.

VSClinical facilitates the clinical analysis of genetic variants in accordance with ACMG and AMP guidelines. Its structured workflow supports adherence to the American College of Medical Genetics (ACMG) standards, which are essential for identifying and categorizing pathogenic variants related to inherited disease risk, cancer susceptibility, and rare disease diagnosis. The combined ACMG/AMP guidelines for variant interpretation establish a framework for scoring variants and categorizing them into one of five classification levels. Implementing these guidelines necessitates a thorough examination of annotations, genomic contexts, and pre-existing clinical insights for each variant. VSClinical streamlines this process by offering a customized workflow that evaluates each relevant criterion and supplies comprehensive bioinformatics, literature references, and clinical knowledgebase evidence to aid in the scoring and interpretation of variants. This innovative approach is designed to enhance the efficiency of variant scientists as they navigate the complexities of variant processing and analysis. Overall, VSClinical stands out as a vital tool for accelerating the understanding and classification of genetic variants in clinical settings.

Techcyte develops innovative machine learning applications specifically for cellular and liquid-based environments, designed to enhance the capabilities of laboratories and professionals in the field of digital diagnostics. Our commitment is to provide comprehensive solutions that offer a seamless and effective user experience at every stage, from sample preparation through to workflow execution and image interpretation, ensuring that we consistently deliver reliable outcomes. We recognize that the most significant breakthroughs in technology and healthcare stem from the ingenuity and dedication of talented individuals. Notably, our Cervical Cytology System serves as a groundbreaking screening instrument, enabling cytotechnologists and pathologists to analyze Hologic ThinPrep® or BD SurePath™ slides with greater efficiency by dramatically minimizing the number of cells they need to assess, all while highlighting the most diagnostically critical cells and organisms through our advanced AI-driven algorithm, optimized laboratory workflows, and integration with Laboratory Information Systems (LIS). This innovative approach not only streamlines the diagnostic process but also elevates the overall quality of patient care.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

No matter the scale of your clinic or your location, MOSAIQ Plaza* equips you with the essential digital tools to provide exceptional multidisciplinary care for your patients—ensuring consistency, reliability, and security throughout their journey from diagnosis to survivorship while generating valuable real-world evidence. Elekta has introduced robust solution packages designed to boost your team's ability to provide care and optimize treatment workflows, allowing you to concentrate on your primary focus: your patients. As we pave the way for the future of multidisciplinary cancer care, MOSAIQ 3 establishes new benchmarks in oncology workflow and information management. Experience the advantages of effortless access to the MOSAIQ Plaza environment, which leads to remarkable efficiencies and a more streamlined operational experience, ultimately enhancing patient outcomes and satisfaction.

Achieve a comprehensive understanding of your research operations by utilizing a robust and standardized clinical trial management system that has been developed in partnership with prominent academic medical and cancer centers. Streamline billing designation processes to promote uniformity across various teams and systems. Enhance your budgeting strategies, ensure accurate routing of charges, and perform more effective audits and monitoring of billing compliance. This integrated approach provides deep visibility and insight into all elements of clinical research, particularly in financial management, thanks to collaboration with elite research institutions. Moreover, by connecting OnCore with your existing electronic medical records (EMR), including seamless integrations with Epic and Cerner, you can significantly boost patient safety, minimize redundant data entry, improve billing compliance, and elevate overall operational efficiency. Ultimately, this system not only simplifies processes but also fosters a more effective research environment.

Over the past twenty years, collaboration with innovative thinkers has enabled the identification, understanding, and reduction of errors from biopsy to data, resulting in significant advancements in tissue data mining tools, precision, workflow, and automation. Explore the realm of image analysis and tissue mining in both multi and highplexed images, where you can extract clinically significant patterns that provide insights into diseases, transforming your research tissue images into valuable knowledge. Discover the capabilities of CE-IVD APPs and workflows in image analysis, and redefine the approach to standardization through AI-powered pathology solutions that enhance diagnostic decision-making. The app center serves as your entry point to an extensive library filled with AI-driven applications, including those designed to adapt to your specific requirements. Additionally, you can peruse our collection of publications, guides, webinars, and posters to deepen your understanding of digital pathology and see how our software continually supports our clients in their research efforts. Embrace the future of pathology by leveraging these innovative tools and resources to elevate your work and contribute to advancing medical science.

The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.

By fostering robust partnerships with top Contract Research Organizations (CROs), we provide an innovative approach to the secure onboarding and evaluation of research studies. Our exceptional user experience in study management and image analysis, combined with integrated artificial intelligence, greatly enhances the productivity of our pathologists. The cutting-edge cloud-based system facilitates immediate collaboration between pharmaceutical companies and CRO partners globally, regardless of location. Users maintain comprehensive control over the configuration of their studies, accommodating various types of associated data, study sizes, and formats from Whole Slide Imaging (WSI) vendors, including capabilities for SEND data representation and LIMS integration, all presented through an easy-to-navigate interface. We combine efficient workflow design, outstanding viewing performance, and user-friendliness to create a distinctly superior digital pathology experience. Patholytix Preclinical stands as a fully scalable solution that adapts to the evolving needs of your organization, ensuring seamless access to studies whether in the office or working remotely. This adaptability not only enhances operational efficiency but also empowers teams to collaborate more effectively in a rapidly changing research landscape.

DoraysLab provides cutting-edge software solutions tailored for pathology, radiology, and diagnostic laboratories. Our intuitive Pathology Lab Software, Radiology Lab Software, and Diagnostic Lab Software simplify the management of laboratory tasks. By utilizing our Lab Management Software and LIMS Software, you can consolidate data, automate workflows, and improve the overall efficiency of your laboratory operations. This not only saves time but also contributes to more accurate and reliable lab results.

EDGE, a cloud-based Clinical Trials Management System, has been successfully integrated into the UK's clinical research infrastructure and the devolved countries. Currently, EDGE is used in 80% of England's NHS regions, Scotland, and Northern Ireland. EDGE is the leading research management system in the UK. EDGE was launched in 2000 and adopted by the National Cancer Research Network. It has seen tremendous growth and has a growing number international subscribers from countries which include Canada, Belgium, New Zealand, South Africa and India.

Mosio allows research teams to improve subject adhesion, communications, data collection, and communication on mobile's most popular channel, text messaging. Our software helps research teams communicate more efficiently with participants by delivering interactive elements to mobile phones and messaging automation. WHO CAN WE HELP? + Clinical Trial Sponsors (Pharma & Biotech) + Cancer Centers and Clinical Research Organizations + NIH-Funded Studies + Public Health Agencies + Clinical Trial Managers/Directors and Clinical Operations Managers/Directors. Clinical Project Managers. Principal Investigators. Clinical Research (Study). Coordinators. All research staff who regularly communicate with study participants. BENEFITS + Interactive medication reminders and medication compliance alerts + Automate data collection. + Increase engagement and adherence. + Get SMS appointment reminders to fix your no-show problem. + Increase retention with automated check ins

sLis Enterprise® Suite for Clinical & Radiology Laboratories has been developed through extensive research, design, and expertise accumulated over years by the IT professionals at INFOMED in the diagnostic and radiology sectors. This advanced Information System is not only cutting-edge but also designed with the flexibility needed to cater to any Laboratory Department while maintaining a user-friendly interface. Its highly customizable nature allows it to adapt to the specific needs and complexities of various laboratories. Functioning as a powerful, swift, and intuitive Laboratory Information System (LIS), sLis Enterprise® creates a cohesive working environment for all diagnostic divisions, including Clinical Chemistry, Hematology, Coagulation, Immunology, Serology, Microbiology, Pathology, Cytology, and Molecular Biology, all utilizing a single database that promotes seamless information sharing among laboratory personnel. Furthermore, it serves as a pioneering instrument for Quality Control Management throughout all sections of the laboratory, enhancing efficiency and accuracy in diagnostic processes. The integration of these features positions sLis Enterprise® as a vital asset for modern laboratory operations.

HCLAB is a versatile and practical laboratory information system (LIS) that can be tailored to suit the specific requirements of your laboratory. It is designed to enhance efficiency in everyday operations and is applicable across various medical and diagnostic fields, including hematology, immunology, biochemistry, microbiology, urinalysis, coagulation, and both molecular and anatomical pathology. With its scalable nature, HCLAB is perfect for laboratories of all sizes, ranging from small specialized sites to intricate multi-site healthcare organizations and academic hospitals. The system provides comprehensive information management, covering every aspect from initial test requests to the final reporting and delivery of results. HCLAB offers a smart client workstation that allows clinical personnel to access the system via the web, facilitating order requests and enabling seamless order entry right from the laboratory. Additionally, it effectively manages and monitors samples sent to external laboratories for tests that cannot be conducted in-house, ensuring a smooth workflow throughout the entire testing process. This means that HCLAB not only improves efficiency but also enhances collaboration between different laboratory entities.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

Complion's platform was designed for clinical researchers. Our solution ensures compliance at the highest level with the lowest effort and the most efficiency. This allows you to concentrate on what really matters: improving and advancing patient outcomes. Our eReg solution is available to all clinical trial stakeholders, whether you are a Sponsor, Research Site or CRO. Reduce costs, avoid redundancy and increase staff productivity. You can easily archive, view and get signatures from any device. An audit trail is built into the system to ensure accuracy and eliminate patient safety risks and study conduct. Our clients include hospitals, cancer centers, and medical centers as well as multi-specialty clinics and dedicated research sites.

Apollo Medical Imaging Technology is a pioneering software company focused on enhancing medical imaging through innovative image processing solutions tailored for both clinical and research purposes. Their leading product, MIStar, stands out as a cost-effective and user-friendly software suite that encompasses a wide range of advanced features and versatile cross-modality solutions, catering to the needs of clinicians and original equipment manufacturers alike. MIStar efficiently accommodates several imaging modalities, including CT, MR, NM, and PET, and boasts specialized modules such as CT Perfusion for stroke and various tumors, DSC-MRI for stroke analysis, DCE-MRI for tumor assessments, as well as DWI & ADC, and DTI Fiber Tractography. Additionally, it offers NM Renogram Analysis and Image Fusion capabilities, making it a comprehensive tool in medical imaging. The software also ensures seamless data management and image input via DICOM networking, complemented by an intuitive clinical database that facilitates easy anonymization and archiving of sensitive patient data. This combination of features positions MIStar as a crucial asset in modern medical imaging practices.